IL-21 enhances tumor-specific CTL induction by anti-DR5 antibody therapy. [electronic resource]
Producer: 20060622Description: 6347-55 p. digitalISSN:- 0022-1767
- Adjuvants, Immunologic -- administration & dosage
- Animals
- Antibodies, Monoclonal -- administration & dosage
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Cell Line, Tumor
- Cytotoxicity, Immunologic
- Interleukins -- administration & dosage
- Lymphocyte Activation -- immunology
- Mice
- Mice, Inbred BALB C
- Mice, Inbred C57BL
- Mice, Knockout
- Mice, SCID
- Receptors, TNF-Related Apoptosis-Inducing Ligand
- Receptors, Tumor Necrosis Factor -- immunology
- T-Lymphocytes, Cytotoxic -- immunology
- Interleukin-21
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.